Upload
others
View
7
Download
0
Embed Size (px)
Citation preview
1
Treatment of Diabetes: Medications and Patient Education
DOS CME Course 20111 Oxtober 20101Confidential
Christine L. Ahrens, Pharm.D.NeuroICU Clinical PharmacistDepartment of Pharmacy
© Cleveland Clinic 2011
Objectives
• Describe modalities of diabetes treatment
• Describe insulin injection, titration, counseling
• Describe mechanisms of lipid therapyp py
DOS CME Course 20112 DOS CME Course 2011
2
Modalities of DM treatment
Balance Nutrition
Weight Loss / Glycemic control
MedicationsIncreased Physical
Activity
DOS CME Course 20113 DOS CME Course 2011
DOS CME Course 20114 DOS CME Course 2011
3
ADA/EASD Treatment Tier 1
DOS CME Course 20115 DOS CME Course 2011
ADA/EASD Treatment Tier 2
DOS CME Course 20116 DOS CME Course 2011
4
Initiating medications
• When can I stop these?When can I stop these?
• Does this mean I’m sick?
• Will I need to go to insulin?
• What if I forget?
• Adherence– Can’t predict
– Educate & Anticipate
DOS CME Course 20117 DOS CME Course 2011
Biguanide: Metformin
• How does it work?– Decreasing the amount of sugar (glucose) your body produces
& improves insulin sensitivity
• What will I notice when taking this?• What will I notice when taking this?– Positive
– Lower fasting BS, no weight change, TC, TG, LDL decrease, A1C ↓1.5
– Negative– GI - *diarrhea (10-15%), N/V (7-26%), lactic acidosis (0.03 cases per
1000 patient-years of metformin therapy)
• How do I take this?– Twice daily with food (depends on dosage form)Twice daily with food (depends on dosage form)
DOS CME Course 20118 DOS CME Course 2011
5
Metformin Titration
• Very important to limit side effects 500mg 1-2 times per dayeffects
• Increase every 5-7 days if tolerated
• Step back if side effects continue
g p y
850-1000mg twice daily
Maximum effective doseMaximum effective dose 2000mg daily
DOS CME Course 20119 DOS CME Course 2011
Sulfonylureas
• How does it work?– Enhancing insulin secretion from beta-cells
• What will I notice when taking this?– Positive
– Lower fasting/Post-prandial BS A1C ↓ 1.5
– Negative– Weight gain (2kg), hypoglycemia
• How do I take this?– IR glipizide & glyburide: 30min before meals
– XL & glimeperide: with breakfast
DOS CME Course 201110 DOS CME Course 2011
6
Meglitindes: Nateglinide (Starlix®), Repaglinide (Prandin®)
• How does it work?– Enhance insulin secretion
• What will I notice when taking this?– Positive
– Lower post-prandial BS, A1C ↓1-1.5
– Negative– Hypoglycemia
• How do I take this?– 1-30 minutes before meals three times daily
DOS CME Course 201111 DOS CME Course 2011
Thiazolidinediones: Pioglitazone (Actos®), Rosiglitazone (Avandia®)
• How does it work?– PPRAγ modulator increases insulin sensitivity
• What will I notice when taking this?– Positive
– Decrease fasting BS, A1C ↓0.5-1.4
– Negative– Weight gain, peripheral edema, lipid effects, HF, CVD?
• How do I take this?– Once daily without regard to food
– Take up to 6-8 weeks for full effect
DOS CME Course 201112 DOS CME Course 2011
7
α-Glucosidase Inhibitors: Acarbose (Precose®), Miglitol (Glyset®)
• How does it work?– Slow carbohydrate absorption in intestine
• What will I notice when taking this?– Positive
– Decrease post-prandial BS, A1C ↓ 0.5-0.8
– Negative– Diarrhea (31%), Flatulence (74%), bloating
H d I t k thi ?• How do I take this?– With first bite of food three times daily
DOS CME Course 201113 DOS CME Course 2011
Incretins: exenatide, liraglutide , sitagliptin, saxagliptin
• How does it work?– Increased glucose-dependent insulin secretion
• What will I notice when taking this?What will I notice when taking this?– Positive
– Lower BS, A1C ↓0.5-1, weight loss (exenatide, liraglutide)/neutral, less hypoglycemia (sitagliptin, saxagliptin)
– Negative– Nausea, cost, injectable (exenatide, liraglutide)
• How do I take this?– Exenatide: Injected twice daily before meals– Liraglutide: Injected once dailyLiraglutide: Injected once daily– Sitagliptin/Saxagliptin: Orally once daily
DOS CME Course 201114 DOS CME Course 2011
8
Glucagon-Like Peptide-1 Agonists Updates/Key Points
• Exenatide (Byetta®)– Acute pancreatitis (6 reports to FDA)– Renal dysfunction and acute kidney injury
Label changed Contraindicated CrCl < 30 ml/min and ca tion if CrCl–Label changed: Contraindicated CrCl < 30 ml/min and caution if CrCl 30-50 ml/min
–Initiate at lower doses (5 mcg BID)
• Liraglutide (Victoza®)– Associated with thyroid C-cell tumors (animal data)– Acute pancreatitis
• AACE/ACE GLP-1 agonists preferred to DPP-4 inhibitors as add-on therapy to medications which decrease insulin resistance
DOS CME Course 201115 DOS CME Course 2011
DPP-4 inhibitors Updates/Key Points
• Sitagliptin (Januvia®)– Acute pancreatitis (> 80 case reports)
–Label changed to monitor patients for s/s of pancreatitis
– Increased hypoglycemia risk with insulin and insulinIncreased hypoglycemia risk with insulin and insulin secretagogues
• Saxagliptin (Onglyza®)– Similar to sitagliptin with QD dosing, renal warnings, and efficacy
– No reports of pancreatitis
– CYP 3A4 substrate
• May consider over GLP-1 agonists since oral therapy and less GI effects
16 DOS CME Course 2011
9
Insulin
• How does it work?– Body’s hormone that moves blood sugar into cells
• What will I notice when taking this?– Positive
– Decreased BS, A1C ↓ 1.5-2.5%
– Negative– Hypoglycemia, weight gain
• How do I take this?– Injected 1 – 4 times per day, with and without meals
– Basal vs. Bolus
DOS CME Course 201117 DOS CME Course 2011
Insulin Myths
• Needing insulin means you are failingg y g
• Having to take insulin means you are in bad shape
• Taking insulin is painful
• Once on insulin, you will always be on insulin
T ki i li li i f di b• Taking insulin means complications of diabetes
DOS CME Course 201118 DOS CME Course 2011
10
Injecting insulin
• Strength 100 units/mL
• N dl 29 32 G 5 12 7• Needles 29-32 G; 5-12.7 mm– Use new needle each time
• Stable at room temp 14-28 days
• Syringe / vial– 10 mL (1,000 units)– Needles 1/3cc, 1/2cc, 1cc, 2cc
• Pen/Cartridge– 3 mL (300 units)
• Injection sites
DOS CME Course 201119 DOS CME Course 2011
Types of Insulin
Basal Bolus
• Intermediate– NPH (Humulin/Novolin N)
• Long acting analog– Detemir (Levemir)
– Glargine (Lantus)
• Short acting– Regular (Humulin/Novolin R)
• Rapid acting analogs– Lispro (Humalog)
– Aspart (Novolog)
– Glulisine (Apidra)
DOS CME Course 201120 DOS CME Course 2011
11
Insulin actions
DOS CME Course 201121 DOS CME Course 2011
Titrating Insulin
Nathan et al.DIABETES CARE.2009;32:193
DOS CME Course 201122 DOS CME Course 2011
12
Hypoglycemia
• Symptoms: Confusion, Dizziness, Feeling shaky, y p , , g y,Hunger, Headaches, Irritability, Pounding heart, Pale skin, Sweating, Trembling, Weakness
• Test blood sugar If < 70 treat with 15 g CHO
• Check BS after 15 min repeat tx if needed
• Eat balanced meal/snack with in 1 hour
DOS CME Course 201123 DOS CME Course 2011
Glucometer / Home blood sugar monitoring
• Frequency / Timing– Fasting AM/PM Adjust basal insulin
– 2 hour post-prandial Adjust bolus insulin
• Control Solution
• Test strip coding
• Write for:Write for: – Meter, test strips, lancets, alcohol swabs
DOS CME Course 201124 DOS CME Course 2011
13
DOS CME Course 201125